 |
|
|
| | Monday, February 2, 2009 |
|
|
|
| 5:00 p.m. |
|
Other Tri-Institutional Events
What Is Medicine? The History of Our Present Complaints
Heberden Society Lecture
Charles Rosenberg, Ph.D., Ernest Monrad Professor of the Social Sciences and professor of the history of science, Harvard University
|
| 7:00 p.m. |
|
Club Meetings
Improvisational Theater Group
|
|
| | Tuesday, February 3, 2009 |
|
|
|
| 11:30 a.m. |
|
Thesis Presentations
Fetal Alcohol Syndrome: Neural Mechanisms of the Most Common and Preventable Birth Defect
Melissa Noel, graduate fellow, Rockefeller University
|
| 2:00 p.m. |
|
Other Seminars
IQ Squared Storage
|
| 4:00 p.m. |
|
Pharmacology Seminars
Molecular Mechanism Controlling Estrogen Signaling and Gene Regulation
William Lee Kraus, Ph.D., associate professor, Cornell University
|
| 4:00 p.m. |
|
Center for Studies in Physics and Biology Seminars
Biased Random Walks: How Do Eukaryotic Cells Find Hidden Targets?
Edward C. Cox, Ph.D., professor, Princeton University
|
| 6:45 p.m. |
|
Other Seminars
The Art Market Is Less Ethical than the Stock Market
IQ Squared U.S. Debate
|
|
| | Wednesday, February 4, 2009 |
|
|
|
| 12:00 p.m. |
|
Seminars in Clinical Research
Just One More Bite: The Neurophysiology of Feeding in the Obesogenic Environment
Dana Small, Ph.D., assistant fellow, the John B. Pierce Laboratory, Yale University School of Medicine
|
| 3:00 p.m. |
|
Other Tri-Institutional Events
Reprogramming of Somatic Cell Identity: Mechanisms and Potential Applications
Jacob Hanna, M.D., Ph.D., postdoctoral fellow, Whitehead Institute for Biomedical Research
|
| 4:30 p.m. |
|
MSKCC President's Research Seminar
Apoptosis-based Drug Discovery for Cancer
John Reed, M.D., Ph.D., president and CEO, The Burnham Institute for Medical Research
|
|
| | Thursday, February 5, 2009 |
|
|
|
| 12:00 p.m. |
|
Biochemistry Lectures
PIP2 Signaling at the Neuronal Synapse:
From Normal Physiology to Pathology
Gilbert Di Paolo, Ph.D., assistant professor, department of pathology and cell biology, Columbia University Medical Center
|
| 2:00 p.m. |
|
Other Tri-Institutional Events
Treating Thalassemia: From Transfusion to Engineered Stem Cells
Michel Sadelain, M.D., Ph.D., director, Gene Transfer and Somatic Cell Engineering Facility, and Stephen and Barbara Friedman Chair, department of molecular pharmacology and chemistry, Memorial Sloan-Kettering Cancer Center Evangelia Yannaki, M.D., George Papanicolaou Hospital, Greece, Stem Cell Mobilization in β-Thalassemic Subjects Farid Boulad, M.D., medical director, Pediatric Day Hospital, Memorial Sloan-Kettering Cancer Center, The Upcoming First U.S. Trial of Globin Gene Transfer
|
|
| | Friday, February 6, 2009 |
|
|
|
| 1:00 p.m. |
|
Molecular Pharmacology and Chemistry Program
Molecular Imaging in Oncology: Targeted and Activatable Probes
Jan Grimm, M.D., nuclear medicine resident, department of radiology, Memorial Sloan-Kettering Cancer Center
|
